NCT06096233 Effect of Exercise on Appetite in Response to Meals
| NCT ID | NCT06096233 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Glasgow |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2023-11-06 |
| Primary Completion | 2026-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14 participants in total. It began in 2023-11-06 with a primary completion date of 2026-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial's primary aim is to investigate the acute effect of two exercise bouts (short \[10 minutes\] and long \[30 minutes\]) on appetite and appetite-regulatory hormone responses to a standard meal test. The secondary aim is to investigate when the changes in appetite and appetite-regulatory hormones occur during exercise. As an exploratory aim, the researchers will test if the two exercise bouts influence ad libitum energy intake in the periods after the standard meal test. The researchers will compare three groups (control, short exercise, and prolonged exercise) to see if the exercise bouts affect appetite, appetite-regulatory hormones, and energy intake in healthy men.
Eligibility Criteria
Inclusion Criteria: * Males aged 18 years or older. * Have stable body mass for at least six months (within ±2 kg). Exclusion Criteria: * Females * People who are younger than 18 or older than 65 years old. * Have food allergies. * Have significant contraindications to exercise (e.g., an injury that would inhibit running). * Smoking. * Suffering from metabolic health issues, e.g., history of diabetes, cardiovascular disease, or eating disorders.
Contact & Investigator
James Dorling, PhD
PRINCIPAL INVESTIGATOR
University of Glasgow
Frequently Asked Questions
Who can join the NCT06096233 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 65 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06096233 currently recruiting?
Yes, NCT06096233 is actively recruiting participants. Contact the research team at a.sultan-kheneisr-w.1@research.gla.ac.uk for enrollment information.
Where is the NCT06096233 trial being conducted?
This trial is being conducted at Glasgow, United Kingdom.
Who is sponsoring the NCT06096233 clinical trial?
NCT06096233 is sponsored by University of Glasgow. The principal investigator is James Dorling, PhD at University of Glasgow. The trial plans to enroll 14 participants.